Epilepsy Epidemiology: Global Prevalence, Age Distribution, and Demographic Patterns

Epilepsy affects ~50 million people worldwide (~0.5–1% prevalence). It is one of the most common serious neurological disorders.

Age Distribution (Bimodal)

  • Peak 1: Early childhood (<5 years). Febrile seizures, genetic epilepsies (SCN1A, etc.), congenital malformations, perinatal injury.
  • Peak 2: Older adults (>65 years). Stroke, neurodegenerative disease, brain tumors, trauma, vascular malformations.
  • Lowest incidence in adolescence/early adulthood.

Sex and Gender

Overall similar prevalence. Syndrome-specific differences:

  • Childhood absence epilepsy, photosensitive epilepsy → more common in females.
  • Juvenile myoclonic epilepsy, Lennox-Gastaut → more common in males.

Race/Ethnicity and Geography

  • Higher prevalence in low- and middle-income countries (LMICs) — 2–3x high-income countries.
  • Drivers: Neuroinfections (neurocysticercosis, malaria, meningitis), perinatal injury, limited prenatal care, trauma, genetic founder effects.
  • In U.S., higher prevalence in Black and Hispanic populations vs. White — partly due to socioeconomic disparities, access to care, and comorbidity burden.

Etiologic Factors

  • Genetic: >500 genes implicated; monogenic (channelopathies) and polygenic architectures.
  • Structural/acquired: Stroke, TBI, CNS infections, tumors, cortical malformations, hypoxic-ischemic injury.
  • Unknown: ~50% globally (higher in LMICs due to limited diagnostics).

Treatment Gap

~70% of people with epilepsy in LMICs receive no treatment (WHO). Barriers: cost, stigma, medication access, workforce shortage.

Genetic Disorders - Related Articles